Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07143357 · ClinicalTrials.gov registry record · NA
Mind-body Resilience Program for Cardiac Arrest Survivors and Their Caregivers: Recovering Together After Cardiac Arrest
A NA study of Depression and Anxiety, sponsored by Massachusetts General Hospital.
- Recruiting
- Registry status
- NA
- Development phase
- 84
- Enrollment target
- 1
- Study location
NCT07143357: Recruiting NA study of Depression and Anxiety, sponsored by Massachusetts General Hospital.
NCT07143357 is a NA study of Depression and Anxiety that is actively recruiting participants, run by Massachusetts General Hospital. The registered enrollment target is 84 participants, below the 786-participant average among 679 other Depression trials with a reported enrollment target (89% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT07143357, a NA study of Depression and Anxiety, is actively recruiting participants, sponsored by Massachusetts General Hospital.
- RECRUITING
- Registry status
- NA
- Development phase
- 84 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this study is to pilot two resilience interventions for cardiac arrest survivors and their informal caregivers, Recovering Together after Cardiac Arrest 1 and Recovering Together after Cardiac Arrest 2 . The data the investigators gather in this study will be used to further refine the interventions.
Primary Outcome
Proportion of eligible dyads that consent to participation
Conditions Studied
Interventions
- BEHAVIORAL Recovering Together after Cardiac Arrest 1
- OTHER Recovering Together after Cardiac Arrest 2
Study Locations (1)
Massachusetts
- Massachusetts General Hospital - Boston
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 84 participants |
| Start Date | 2025-10-17 |
| Est. Completion | 2028-07 |
| Phase | NA |
What NCT07143357 shows while recruiting
NCT07143357 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 84 participants, a relatively small participant target, below the 786-participant average among 679 other Depression trials with a reported enrollment target (89% lower).
The record links to 8 conditions, with Depression appearing as the primary indexed condition, and to 2 interventions - of which Recovering Together after Cardiac Arrest 1 is the first listed.
NCT07143357 reports a single indexed study location in Massachusetts.
Frequently Asked Questions
What is clinical trial NCT07143357 about?
NCT07143357 is a clinical study titled "Mind-body Resilience Program for Cardiac Arrest Survivors and Their Caregivers: Recovering Together After Cardiac Arrest". The purpose of this study is to pilot two resilience interventions for cardiac arrest survivors and their informal caregivers, Recovering Together after Cardiac Arrest 1 and Recovering Together after Cardiac Arrest 2 . The data the investigators gather in this study will be used to further refine th...
What is the current status of trial NCT07143357?
This trial is currently recruiting. It is a NA study. The enrollment target is 84 participants. The study started on 2025-10-17. Estimated completion is 2028-07.
What conditions does trial NCT07143357 study?
This clinical trial studies the following conditions: Depression, Anxiety, Survivorship, Mindfulness, Caregivers.
What interventions are being tested in trial NCT07143357?
The interventions under investigation include: Recovering Together after Cardiac Arrest 1 (BEHAVIORAL), Recovering Together after Cardiac Arrest 2 (OTHER).
Who is sponsoring clinical trial NCT07143357?
This trial is sponsored by Massachusetts General Hospital, which has 2,032 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT07143357 being conducted?
This trial has 1 study location across Massachusetts. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Depression
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT07143357's enrollment target sits among peer trials
84 366th of 679 higher than 312 of 679 other Depression trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Depression trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Reaching Out to Distressed Medical Residents, Fellows and Faculty
RECRUITING · NA
-
IMPACT (IMproving Proactive Approaches for Cancer Survivors' Mental Health Treatment)
RECRUITING · NA
-
Cold and Heat Investigation to Lower Levels of Depression
RECRUITING · NA
-
Dosing rTMS for Depression Post-SCI
RECRUITING · NA
-
Exploring Virtual Reality Adventure Training Exergaming
RECRUITING · NA
-
Brief Interventions for Coping with Distress
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02391519 · 84 participants
Effects of High Altitude on AMPK Activation
- NCT03838536 · 84 participants · NA
Synergistic Activity of Human Milk Nutrients and Infant Cognition
- NCT03884075 · 84 participants · Phase 2
Non-Alcoholic Fatty Liver Disease, the HEpatic Response to Oral Glucose, and the Effect of Semaglutide (NAFLD HEROES)
- NCT03894917 · 84 participants
Characterizing Disease Biology, Treatment and Toxicity in Older Adults With Hepatocellular Carcinoma
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT06358040 · started 2026-10 · NA
Opioid Dispenser for Microdiscectomy/Laminectomy